AU1714088A - Creation of Inventions and Patents with Artificial Intelligence

AU1714088A – Cimetidine compositions
– Google Patents

AU1714088A – Cimetidine compositions
– Google Patents
Cimetidine compositions

Info

Publication number
AU1714088A

AU1714088A
AU17140/88A
AU1714088A
AU1714088A
AU 1714088 A
AU1714088 A
AU 1714088A
AU 17140/88 A
AU17140/88 A
AU 17140/88A
AU 1714088 A
AU1714088 A
AU 1714088A
AU 1714088 A
AU1714088 A
AU 1714088A
Authority
AU
Australia
Prior art keywords
cimetidine
compositions
cimetidine compositions
Prior art date
1987-05-08
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)

Granted

Application number
AU17140/88A
Other versions

AU602582B2
(en

Inventor
Kevin Edward Pearmain
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Smith Kline and French Laboratories Ltd

Original Assignee
Smith Kline and French Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
1987-05-08
Filing date
1988-05-04
Publication date
1988-12-06

1987-05-08
Priority claimed from GB878710966A
external-priority
patent/GB8710966D0/en

1987-05-08
Priority claimed from GB878710965A
external-priority
patent/GB8710965D0/en

1988-05-04
Application filed by Smith Kline and French Laboratories Ltd
filed
Critical
Smith Kline and French Laboratories Ltd

1988-12-06
Publication of AU1714088A
publication
Critical
patent/AU1714088A/en

1990-10-18
Application granted
granted
Critical

1990-10-18
Publication of AU602582B2
publication
Critical
patent/AU602582B2/en

2008-05-04
Anticipated expiration
legal-status
Critical

Status
Expired
legal-status
Critical
Current

Links

Espacenet

Global Dossier

Discuss

Classifications

A—HUMAN NECESSITIES

A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE

A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES

A61K31/00—Medicinal preparations containing organic active ingredients

A61K31/33—Heterocyclic compounds

A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins

A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole

A61K31/415—1,2-Diazoles

A—HUMAN NECESSITIES

A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE

A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES

A61K9/00—Medicinal preparations characterised by special physical form

A61K9/0012—Galenical forms characterised by the site of application

A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration

A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals

A—HUMAN NECESSITIES

A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE

A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES

A61K9/00—Medicinal preparations characterised by special physical form

A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles

A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction

A—HUMAN NECESSITIES

A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE

A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES

A61K9/00—Medicinal preparations characterised by special physical form

A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles

A61K9/1605—Excipients; Inactive ingredients

A61K9/1629—Organic macromolecular compounds

A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates

A—HUMAN NECESSITIES

A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE

A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES

A61K9/00—Medicinal preparations characterised by special physical form

A61K9/20—Pills, tablets, discs, rods

A—HUMAN NECESSITIES

A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE

A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES

A61K9/00—Medicinal preparations characterised by special physical form

A61K9/20—Pills, tablets, discs, rods

A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms

A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets

A—HUMAN NECESSITIES

A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE

A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

AU17140/88A
1987-05-08
1988-05-04
Cimetidine compositions

Expired

AU602582B2
(en)

Applications Claiming Priority (4)

Application Number
Priority Date
Filing Date
Title

GB878710966A

GB8710966D0
(en)

1987-05-08
1987-05-08
Pharmaceutical compositions

GB8710965

1987-05-08

GB878710965A

GB8710965D0
(en)

1987-05-08
1987-05-08
Pharmaceutical compositions

GB8710966

1987-05-08

Publications (2)

Publication Number
Publication Date

AU1714088A
true

AU1714088A
(en)

1988-12-06

AU602582B2

AU602582B2
(en)

1990-10-18

Family
ID=26292225
Family Applications (1)

Application Number
Title
Priority Date
Filing Date

AU17140/88A
Expired

AU602582B2
(en)

1987-05-08
1988-05-04
Cimetidine compositions

Country Status (12)

Country
Link

US
(1)

US5188839A
(en)

EP
(1)

EP0290229B1
(en)

JP
(1)

JP2721219B2
(en)

KR
(1)

KR960011236B1
(en)

AU
(1)

AU602582B2
(en)

DE
(1)

DE3863963D1
(en)

ES
(1)

ES2040339T3
(en)

GB
(1)

GB2204489B
(en)

GR
(1)

GR3002410T3
(en)

IE
(1)

IE61692B1
(en)

PT
(1)

PT87423B
(en)

WO
(1)

WO1988008703A1
(en)

Cited By (1)

* Cited by examiner, † Cited by third party

Publication number
Priority date
Publication date
Assignee
Title

AU602583B2
(en)

1987-05-08
1990-10-18
Smith Kline & French Laboratories Limited
Cimetidine compositions

Families Citing this family (45)

* Cited by examiner, † Cited by third party

Publication number
Priority date
Publication date
Assignee
Title

US5286489A
(en)

1985-08-26
1994-02-15
The Procter & Gamble Company
Taste masking compositions

DE3809764A1
(en)

1988-03-23
1989-10-05
Knoll Ag

MIXTURE OF ALGINATES AND POLYACRYLATES AND THEIR USE

US5230901A
(en)

1988-03-23
1993-07-27
Knoll Ag
Sustained release tablet of a mixture of alginates and polyacrylates

ES2052911T3
(en)

1988-05-04
1994-07-16
Smith Kline French Lab

CHEWABLE TABLET.

US5219563A
(en)

1988-05-11
1993-06-15
Glaxo Group Limited
Drug adsorbates

DE3931215C2
(en)

1988-09-20
1998-07-16
Glaxo Group Ltd

Pharmaceutical preparations based on ranitidine

ZA919510B
(en)

1990-12-05
1992-10-28
Smithkline Beecham Corp
Pharmaceutical compositions

EP0587744B1
(en)

1991-05-28
2003-07-16
McNEIL-PPC, Inc.
Chewable drug-delivery composition

US5380535A
(en)

1991-05-28
1995-01-10
Geyer; Robert P.
Chewable drug-delivery compositions and methods for preparing the same

EG20380A
(en)

1991-10-16
1999-02-28
Richardson Vicks Inc
Enhanced skin penetration system for improved topical delivery of drugs

GB9127150D0
(en)

1991-12-20
1992-02-19
Smithkline Beecham Plc
Novel treatment

US5294433A
(en)

1992-04-15
1994-03-15
The Procter & Gamble Company
Use of H-2 antagonists for treatment of gingivitis

DE69331948T2
(en)

1992-06-04
2002-11-28
Smithkline Beecham Corp

PLEASANT TASTING PHARMACEUTICAL COMPOSITIONS

GB9224855D0
(en)

1992-11-27
1993-01-13
Smithkline Beecham Plc
Pharmaceutical compositions

CA2110313C
(en)

1992-12-01
2004-10-26
Edward John Roche
Pharmaceutical compositions containing a guanidinothiazole compound and antacids

US5622980A
(en)

1993-08-17
1997-04-22
Applied Analytical Industries, Inc.
Oral compositions of H2-antagonists

US6818229B1
(en)

1993-09-20
2004-11-16
Kos Pharmaceuticals, Inc.
Intermediate release nicotinic acid compositions for treating hyperlipidemia

US20060263428A1
(en)

1993-09-20
2006-11-23
Eugenio Cefali
Methods for treating hyperlipidemia with intermediate release nicotinic acid compositions having unique biopharmaceutical characteristics

US6129930A
(en)

1993-09-20
2000-10-10
Bova; David J.
Methods and sustained release nicotinic acid compositions for treating hyperlipidemia at night

US6676967B1
(en)

1993-09-20
2004-01-13
Kos Pharmaceuticals, Inc.
Methods for reducing flushing in individuals being treated with nicotinic acid for hyperlipidemia

US6746691B2
(en)

1993-09-20
2004-06-08
Kos Pharmaceuticals, Inc.
Intermediate release nicotinic acid compositions for treating hyperlipidemia having unique biopharmaceutical characteristics

US6080428A
(en)

1993-09-20
2000-06-27
Bova; David J.
Nicotinic acid compositions for treating hyperlipidemia and related methods therefor

SE9600071D0
(en)

†

1996-01-08
1996-01-08
Astra Ab

New oral formulation of two active ingredients I

DK0906089T3
(en)

1996-05-13
2003-12-08
Novartis Consumer Health Sa

The buccal delivery system

US8071128B2
(en)

1996-06-14
2011-12-06
Kyowa Hakko Kirin Co., Ltd.
Intrabuccally rapidly disintegrating tablet and a production method of the tablets

JP3797387B2
(en)

1996-06-14
2006-07-19
協和醗酵工業株式会社

Orally disintegrating tablet

WO1998014198A1
(en)

1996-10-04
1998-04-09
Merck & Co., Inc.
Methods and compositions for preventing and treating heartburn

US5989588A
(en)

1996-10-04
1999-11-23
Merck & Co., Inc.
Methods and compositions for preventing and treating heartburn

FR2766089B1
(en)

1997-07-21
2000-06-02
Prographarm Lab

IMPROVED MULTIPARTICULAR TABLET WITH RAPID DELIVERY

IN186245B
(en)

1997-09-19
2001-07-14
Ranbaxy Lab Ltd

EP1140066A4
(en)

1998-11-17
2005-11-09
Nitromed Inc
Nitrosated and nitrosylated h2 receptor antagonist compounds, compositions and methods of use

FR2794979B1
(en)

1999-06-21
2001-07-27
Patrick Veret

A NEW FORMULATION OF TABLET COMPOSED OF LACTOSE, SORBITOL, MAGNESIUM STEARATE

US6551617B1
(en)

2000-04-20
2003-04-22
Bristol-Myers Squibb Company
Taste masking coating composition

PT1276470E
(en)

2000-04-20
2007-08-13
Novartis Ag
Taste masking coating composition

US9358214B2
(en)

2001-10-04
2016-06-07
Adare Pharmaceuticals, Inc.
Timed, sustained release systems for propranolol

US20030170310A1
(en)

2002-03-08
2003-09-11
Hardeep Wadhwa
Tasteless, directly compressible, fast-dissolving complexes and pharmaceutical formulations thereof

US8367111B2
(en)

2002-12-31
2013-02-05
Aptalis Pharmatech, Inc.
Extended release dosage forms of propranolol hydrochloride

ITMI20041255A1
(en)

2004-06-22
2004-09-22
Univ Degli Studi Milano

MICROPARTICLE SYSTEMS FOR ORAL ADMINISTRATION OF BIOLOGICALLY ACTIVE SUBSTANCES

US8747895B2
(en)

2004-09-13
2014-06-10
Aptalis Pharmatech, Inc.
Orally disintegrating tablets of atomoxetine

US20060127479A1
(en)

2004-10-08
2006-06-15
Natrajan Kumaraperumal
Solvent free taste masked pharmaceutical compositions

US9884014B2
(en)

2004-10-12
2018-02-06
Adare Pharmaceuticals, Inc.
Taste-masked pharmaceutical compositions

AU2005299490C1
(en)

2004-10-21
2012-01-19
Adare Pharmaceuticals, Inc.
Taste-masked pharmaceutical compositions with gastrosoluble pore-formers

US9161918B2
(en)

2005-05-02
2015-10-20
Adare Pharmaceuticals, Inc.
Timed, pulsatile release systems

EP1983827A4
(en)

2006-02-01
2013-07-10
Stuart L Weg
Use of antifungal compositions to treat upper gastrointestinal conditions

CN102958515A
(en)

2009-12-02
2013-03-06
阿普塔利斯制药有限公司
Fexofenadine microcapsules and compositions containing them

Family Cites Families (10)

* Cited by examiner, † Cited by third party

Publication number
Priority date
Publication date
Assignee
Title

JPS5840529B2
(en)

1975-09-29
1983-09-06
明治製菓株式会社

Keikouyou Seizaino Seiho

JPS5513239A
(en)

1978-07-14
1980-01-30
Fujisawa Pharmaceut Co Ltd
Fine particulate drug composition

JPS5567375A
(en)

1978-11-17
1980-05-21
Harunobu Miura
Automatic washer

JPS56164122A
(en)

1980-05-21
1981-12-17
Fujimoto Seiyaku Kk
Drug composition comprising cimetidine as main agent

JPS58201725A
(en)

1982-05-19
1983-11-24
Eisai Co Ltd
Composition for preventing browning

EP0205336B1
(en)

1985-06-11
1991-09-11
Teijin Limited
Oral sustained release pharmaceutical preparation

FR2593065B1
(en)

1986-01-22
1988-09-09
Smith Kline French Lab

EFFERVESCENT COUPLES, EFFERVESCENT COMPOSITIONS OF HISTAMINE H2 ANTAGONISTS CONTAINING THEM AND THEIR PREPARATION.

US4800087A
(en)

1986-11-24
1989-01-24
Mehta Atul M
Taste-masked pharmaceutical compositions

JPS63188621A
(en)

1987-01-30
1988-08-04
Taisho Pharmaceut Co Ltd
Flavor oral preparation

GB8710965D0
(en)

1987-05-08
1987-06-10
Smith Kline French Lab
Pharmaceutical compositions

1987

1987-05-04
KR
KR1019890700007A
patent/KR960011236B1/en
not_active
IP Right Cessation

1988

1988-05-04
DE
DE8888304007T
patent/DE3863963D1/en
not_active
Expired – Lifetime

1988-05-04
EP
EP88304007A
patent/EP0290229B1/en
not_active
Expired – Lifetime

1988-05-04
AU
AU17140/88A
patent/AU602582B2/en
not_active
Expired

1988-05-04
JP
JP63503930A
patent/JP2721219B2/en
not_active
Expired – Lifetime

1988-05-04
GB
GB8810477A
patent/GB2204489B/en
not_active
Revoked

1988-05-04
ES
ES198888304007T
patent/ES2040339T3/en
not_active
Expired – Lifetime

1988-05-04
US
US07/295,190
patent/US5188839A/en
not_active
Expired – Lifetime

1988-05-04
WO
PCT/GB1988/000349
patent/WO1988008703A1/en
unknown

1988-05-05
PT
PT87423A
patent/PT87423B/en
not_active
IP Right Cessation

1988-05-06
IE
IE136888A
patent/IE61692B1/en
not_active
IP Right Cessation

1991

1991-08-01
GR
GR91401072T
patent/GR3002410T3/en
unknown

Cited By (1)

* Cited by examiner, † Cited by third party

Publication number
Priority date
Publication date
Assignee
Title

AU602583B2
(en)

1987-05-08
1990-10-18
Smith Kline & French Laboratories Limited
Cimetidine compositions

Also Published As

Publication number
Publication date

WO1988008703A1
(en)

1988-11-17

ES2040339T3
(en)

1993-10-16

IE881368L
(en)

1988-11-08

DE3863963D1
(en)

1991-09-05

JP2721219B2
(en)

1998-03-04

GB8810477D0
(en)

1988-06-08

KR890701101A
(en)

1989-12-19

US5188839A
(en)

1993-02-23

EP0290229A1
(en)

1988-11-09

GB2204489B
(en)

1990-11-14

GB2204489A
(en)

1988-11-16

PT87423A
(en)

1989-05-31

GR3002410T3
(en)

1992-12-30

PT87423B
(en)

1992-09-30

JPH01503385A
(en)

1989-11-16

AU602582B2
(en)

1990-10-18

EP0290229B1
(en)

1991-07-31

KR960011236B1
(en)

1996-08-21

IE61692B1
(en)

1994-11-16

Contact information